Lundbeck
HLUN-B.CO
#2346
Rank
C$8.86 B
Marketcap
$9.16
Share price
0.98%
Change (1 day)
26.93%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$3.09 B

According to Lundbeck 's latest financial reports the company's total liabilities are C$3.09 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lundbeck - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$3.01 B-7.38%
2022-12-31C$3.25 B3.27%
2021-12-31C$3.15 B-21.46%
2020-12-31C$4.01 B-3.21%
2019-12-31C$4.14 B126.66%
2018-12-31C$1.83 B19.25%
2017-12-31C$1.53 B-23.27%
2016-12-31C$2.00 B-21.59%
2015-12-31C$2.55 B11.23%
2014-12-31C$2.29 B14.55%
2013-12-31C$2.00 B35.48%
2012-12-31C$1.47 B7.53%
2011-12-31C$1.37 B11.81%
2010-12-31C$1.22 B-27.21%
2009-12-31C$1.68 B46.81%
2008-12-31C$1.15 B16.65%
2007-12-31C$0.98 B-1.81%
2006-12-31C$1.00 B31.75%
2005-12-31C$0.76 B4.6%
2004-12-31C$0.72 B